Defunct Company
Total Trials
17
As Lead Sponsor
15
As Collaborator
2
Total Enrollment
4,768
NCT00045123
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2002
Completion: Not specified
NCT00105547
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
Phase: Phase 3
Start: Feb 28, 2005
Completion: May 31, 2008
NCT00394446
Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors
Phase: Phase 1
Start: Mar 31, 2005
Completion: Feb 29, 2008
NCT00393965
Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases
Start: Dec 31, 2005
NCT00511368
Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Start: Apr 30, 2006
Completion: Jul 31, 2008
NCT00322036
Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
Start: May 31, 2006
Completion: Dec 31, 2008
NCT00380276
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
Start: Sep 30, 2006
NCT00478686
Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine
Phase: N/A
Role: Collaborator
Start: May 23, 2007
Completion: May 2, 2017
NCT00609011
Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma
Phase: Phase 1/2
Start: Mar 31, 2008
Completion: Aug 31, 2009
NCT00635557
Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
Completion: Aug 31, 2011
NCT00967187
Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.
Start: May 31, 2008
Completion: Dec 31, 2009
NCT01097070
A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days
Start: Nov 30, 2008
Completion: Jan 31, 2009
NCT00892931
Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
Start: Apr 30, 2009
Completion: Sep 30, 2011
NCT00920205
Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments
Start: Jun 30, 2009
Completion: Jun 30, 2011
NCT01026727
A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Start: Nov 30, 2009
Completion: Jun 30, 2010
NCT01285414
Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme
Start: Dec 31, 2010
Completion: Mar 31, 2012
NCT04396808
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Start: Nov 5, 2020
Completion: Dec 31, 2025